Neurosurgical resection of multiple brain metastases: outcomes, complications, and survival rates in a retrospective analysis.

IF 3.2 2区 医学 Q2 CLINICAL NEUROLOGY
Journal of Neuro-Oncology Pub Date : 2024-09-01 Epub Date: 2024-06-21 DOI:10.1007/s11060-024-04744-w
Sebastian Niedermeyer, M Schmutzer-Sondergeld, J Weller, S Katzendobler, S Kirchleitner, R Forbrig, P N Harter, L V Baumgarten, C Schichor, V Stoecklein, N Thon
{"title":"Neurosurgical resection of multiple brain metastases: outcomes, complications, and survival rates in a retrospective analysis.","authors":"Sebastian Niedermeyer, M Schmutzer-Sondergeld, J Weller, S Katzendobler, S Kirchleitner, R Forbrig, P N Harter, L V Baumgarten, C Schichor, V Stoecklein, N Thon","doi":"10.1007/s11060-024-04744-w","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>This study investigates the outcomes of microsurgical resection of multiple brain metastasis (BMs).</p><p><strong>Methods: </strong>This retrospective, monocentric analysis included clinical data from all consecutive BM patients, who underwent simultaneous resection of ≥ 2 BMs between January 2018 and May 2023. Postoperative neurological and functional outcomes, along with perioperative complications, as well as survival data were evaluated.</p><p><strong>Results: </strong>A total of 47 patients, with a median age of 61 years (IQR 48-69), underwent 73 craniotomies (median 2; range 1-3) for resection of 104 BMs. Among patients, 80.8% presented with symptomatic BMs, causing focal neurological deficits in 53% of cases. Gross total resection was achieved in 87.2% of BMs. Karnofsky Performance Scale (KPS) scores improved in 42.6% of patients, remained unchanged in 46.8%, and worsened in 10.6% after surgery. Perioperative complications were observed in 29.8% of cases, with transient complications occurring in 19.2% and permanent deficits in 10.6%. The 30-days mortality rate was 2.1%. Logistic regression identified eloquent localization (p = 0.036) and infratentorial craniotomy (p = 0.018) as significant predictors of postoperative complications. Concerning overall prognosis, patients with permanent neurological deficits post-surgery (HR 11.34, p = 0.007) or progressive extracranial disease (HR: 4.649; p = 0.006) exhibited inferior survival.</p><p><strong>Conclusion: </strong>Microsurgical resection of multiple BMs leads to clinical stabilization or functional improvement in most patients. Although transient complications do not affect overall survival, the presence of persistent neurological deficits (> 3 months post-surgery) and progressive extracranial disease negatively impact overall survival. This highlights the importance of careful patient selection for resection of multiple BMs.</p>","PeriodicalId":16425,"journal":{"name":"Journal of Neuro-Oncology","volume":null,"pages":null},"PeriodicalIF":3.2000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11341644/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Neuro-Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11060-024-04744-w","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/6/21 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: This study investigates the outcomes of microsurgical resection of multiple brain metastasis (BMs).

Methods: This retrospective, monocentric analysis included clinical data from all consecutive BM patients, who underwent simultaneous resection of ≥ 2 BMs between January 2018 and May 2023. Postoperative neurological and functional outcomes, along with perioperative complications, as well as survival data were evaluated.

Results: A total of 47 patients, with a median age of 61 years (IQR 48-69), underwent 73 craniotomies (median 2; range 1-3) for resection of 104 BMs. Among patients, 80.8% presented with symptomatic BMs, causing focal neurological deficits in 53% of cases. Gross total resection was achieved in 87.2% of BMs. Karnofsky Performance Scale (KPS) scores improved in 42.6% of patients, remained unchanged in 46.8%, and worsened in 10.6% after surgery. Perioperative complications were observed in 29.8% of cases, with transient complications occurring in 19.2% and permanent deficits in 10.6%. The 30-days mortality rate was 2.1%. Logistic regression identified eloquent localization (p = 0.036) and infratentorial craniotomy (p = 0.018) as significant predictors of postoperative complications. Concerning overall prognosis, patients with permanent neurological deficits post-surgery (HR 11.34, p = 0.007) or progressive extracranial disease (HR: 4.649; p = 0.006) exhibited inferior survival.

Conclusion: Microsurgical resection of multiple BMs leads to clinical stabilization or functional improvement in most patients. Although transient complications do not affect overall survival, the presence of persistent neurological deficits (> 3 months post-surgery) and progressive extracranial disease negatively impact overall survival. This highlights the importance of careful patient selection for resection of multiple BMs.

Abstract Image

神经外科切除多发性脑转移瘤:回顾性分析中的结果、并发症和存活率。
目的:本研究探讨显微外科切除多发脑转移瘤(BMs)的疗效:这项回顾性、单中心分析纳入了所有连续脑转移瘤患者的临床数据,这些患者在2018年1月至2023年5月期间接受了同时切除≥2个脑转移瘤的手术。对术后神经和功能预后、围手术期并发症以及生存数据进行了评估:共有47名患者,中位年龄61岁(IQR 48-69),接受了73次开颅手术(中位2次;范围1-3次),切除了104个BMs。在患者中,80.8%的患者伴有有症状的骨髓瘤,53%的病例导致局灶性神经功能缺损。87.2%的骨髓瘤实现了全切除。手术后,42.6%的患者卡诺夫斯基表现量表(KPS)评分有所改善,46.8%的患者评分保持不变,10.6%的患者评分恶化。29.8%的病例出现围手术期并发症,其中19.2%的病例出现一过性并发症,10.6%的病例出现永久性功能障碍。30天死亡率为2.1%。逻辑回归结果表明,有声定位(p = 0.036)和幕下开颅(p = 0.018)是术后并发症的重要预测因素。关于总体预后,术后出现永久性神经功能缺损(HR 11.34,p = 0.007)或颅外疾病进展(HR:4.649;p = 0.006)的患者生存率较低:结论:显微手术切除多发性骨髓瘤可使大多数患者的临床病情稳定或功能改善。尽管一过性并发症不会影响总生存率,但持续性神经功能缺损(术后超过 3 个月)和进行性颅外疾病会对总生存率产生负面影响。这凸显了在切除多发性骨髓瘤时谨慎选择患者的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Neuro-Oncology
Journal of Neuro-Oncology 医学-临床神经学
CiteScore
6.60
自引率
7.70%
发文量
277
审稿时长
3.3 months
期刊介绍: The Journal of Neuro-Oncology is a multi-disciplinary journal encompassing basic, applied, and clinical investigations in all research areas as they relate to cancer and the central nervous system. It provides a single forum for communication among neurologists, neurosurgeons, radiotherapists, medical oncologists, neuropathologists, neurodiagnosticians, and laboratory-based oncologists conducting relevant research. The Journal of Neuro-Oncology does not seek to isolate the field, but rather to focus the efforts of many disciplines in one publication through a format which pulls together these diverse interests. More than any other field of oncology, cancer of the central nervous system requires multi-disciplinary approaches. To alleviate having to scan dozens of journals of cell biology, pathology, laboratory and clinical endeavours, JNO is a periodical in which current, high-quality, relevant research in all aspects of neuro-oncology may be found.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信